Clinical Trials News

ORLANDO, Fla.--(BUSINESS WIRE)--Study shows Kerecis fish-skin grafts reduce hospital stays for burn patients by 9.3 days compared to synthetic grafts, with lower complication rates....

SOUTHLAKE, Texas & YOKNEAM, Israel--(BUSINESS WIRE)--FDA clears TIGERTRIEVER™ 25 adjustable thrombectomy device by Rapid Medical; first U.S. cases show first-pass success in ischemic stroke....

OTTAWA, Ontario--(BUSINESS WIRE)--Fullscript, a provider-led health platform doing over $1B in revenue annually, used by more than 125,000 healthcare providers and more than 5 million patients annually across North America, today announced the general availability of Fullscript Journeys, a new product that gives practitioners the technology to deliver modern, consumer-grade health experiences while keeping clinical guidance at the center of care. With journeys, Fullscript is taking the Shopify...

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--SEQSTER PDM, Inc. (“SEQSTER”), the leading healthcare technology company powering the connection, collection, and orchestration layer of patient health data, today launched 1-Click Sites, a new product that enables clinical sites to seamlessly share patient-consented EHR data with trial sponsors. SEQSTER also announced a partnership with BioIVT, LLC (“BioIVT”), the leading provider of human biological products for drug discovery and development, which will...

SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced it will present new data at the AACR Annual Meeting 2026 demonstrating how integrated, patient-derived platforms can accelerate the development of complex oncology modalities, including antibody-drug conjugates (ADCs) and radiopharmaceuticals. Across 12 poster presentations, the company highlights scalable approaches to improve target selection, optimize p...

NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled “Home-Based Biofeedback for Fecal Incontinence: A Randomized Clinical Trial” in Urogynecology, the official journal of the American Urogynecologic Society (AUGS), demonstrating the effectiveness of the Leva Pelvic Health System in treating fecal incontinence (FI) in...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore open-label extension data from the company’s investigation of EPX-100 (clemizole hydrochloride) in the ongoing Phase 3 ARGUS trial for the treatment of Dravet syndrome at the 2026 American Academy of Neurology Annual Meeting being held April 18 – 22 in Chicago, IL. The ARGUS trial is currently enrolling, and more information about the trial can be found at argust...

BOSTON--(BUSINESS WIRE)--Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a drug discovery company developing breakthrough medicines through AI-enhanced computational chemistry, today announced that it is presenting new mechanistic data on its novel salt-inducible kinase 2 (SIK2) inhibitor program at IMMUNOLOGY2026™, the 109th annual meeting of the American Association of Immunologists (AAI), taking place April 15–19, 2026, in Boston, Massachusetts. Salt-inducible kinases (SIKs) co...

MAHWAH, NJ--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock management at 8:00 a.m. ET. To access the live audio webcast, please go to “Events and Presentations” in the Investors section of the Scholar Rock website at http://investors.scholarrock.com. To participate via telephone, please reg...